BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2019
View Archived Issues
Tonix, Massachusetts General Hospital enter collaboration to develop MAb for transplant rejection
Read More
Scioto Biosciences receives NIH grant to develop novel probiotic therapy
Read More
Model recapitulates anti-NMDA receptor encephalitis via active immunization
Read More
Neglected neuraminidase may explain flu vaccine failures
Read More
TREM2 may play role in AD patients without risk variant
Read More
Muscle-generated BDNF found to control metabolic flexibility
Read More
Approved calcium channel antagonists identified for repurposing to treat Pitt Hopkins Syndrome
Read More
Zebrafish screening platform can identify therapeutics for spinal cord injury
Read More
Allergan enrolling in phase III long-term extension study of brazikumab for Crohn's disease
Read More
Rocket announces clearance for phase II registration-enabling FANCOLEN-II study of RP-L102
Read More
Phase III FORT study of fosmetpantotenate does not meet primary endpoint
Read More
Zydus initiates phase II EVIDENCES VII study of saroglitazar magnesium in NAFLD with PCOS
Read More
Novel mouse model of human optic atrophy syndrome
Read More
Phase I results for AZD-1775 plus gemcitabine in locally advanced pancreatic cancer
Read More
CARB-X funds development of vaccine against carbapenem-resistant superbug Klebsiella pneumoniae
Read More
New tubulin polymerization inhibitors identified at the University of Sydney
Read More
Medshine Discovery identifies Janus kinase inhibitors
Read More
High affinity nerve growth factor receptor inhibitors patented by Shanghai GeneChem
Read More
Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine disclose F2RL3 antagonists
Read More
Sunshine Lake Pharma discovers sodium/glucose cotransporter 1 inhibitors
Read More
HMPL-523 begins phase I trial in China for ITP
Read More
DREAMM-2 study of belantamab mafodotin in relapsed multiple myeloma meets primary objective
Read More
FDA accepts Seelos' IND for phase IIb/III study of SLS-005 for MPS III
Read More